Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Water Reduces Nerve Pain in Mice Study

Molecular hydrogen attenuates neuropathic pain in mice

Research hubs: Brain & Nervous System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Molecular hydrogen attenuates neuropathic pain in mice
Evidence type
Animal study (mouse)
Authors
Masanori Kawaguchi, Yasushi Satoh, Yukiko Otsubo, Tomiei Kazama
Journal
PLoS One
Year
2014
Study Type
Mouse
Delivery
Water, Commercial (Blue Mercury)
Dose
hydrogen-saturated water ad libitum for 3 weeks, with subgroup analyses for induction phase (days 0-4) and maintenance phase (days 4-21)
H₂ concentration
saturated level
Duration
3 weeks
Outcome
Positive
Peer Reviewed
Yes
Cited by
50 (OpenAlex, as of November 2026)
Country
Japan

TL;DR

Drinking hydrogen-enriched water can reduce nerve pain and damage in mice by lowering oxidative stress.

Key Finding

Drinking hydrogen-enriched water reduced both mechanical pain sensitivity and heat sensitivity in mice with nerve injuries, particularly when administered during the early phase after injury.

Summary

Researchers tested whether drinking water containing molecular hydrogen could reduce nerve pain in mice with a specific type of nerve injury. Mice that drank hydrogen-enriched water showed reduced pain responses compared to controls, and the treatment appeared to work by reducing harmful molecules called oxidative stress in the nervous system. The treatment was most effective when given early after the nerve injury occurred.

Practical Takeaway

This is an early-stage animal study suggesting hydrogen water may help with neuropathic pain by reducing oxidative stress in nerve tissue. However, results in mice do not automatically translate to humans, and no human trials have been conducted yet. More research, including human studies, would be needed before drawing conclusions about effectiveness in people with nerve pain.

Abstract (excerpt)

Neuropathic pain remains intractable and the development of new therapeutic strategies are urgently required. Accumulating evidence indicates that overproduction of oxidative stress is a key event in the pathogenesis of neuropathic pain. However, repeated intra-peritoneal or intrathecal injections…

Read the full abstract on PubMed